Neurotech Devices Market Size

  • Report ID: 6050
  • Published Date: Sep 17, 2025
  • Report Format: PDF, PPT

Neurotech Devices Market Outlook:

Neurotech Devices Market size was valued at USD 16.16 billion in 2025 and is expected to reach USD 61.5 billion by 2035, expanding at around 14.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of neurotech devices is evaluated at USD 18.24 billion.

The reason behind the growth is the rising cases of neurological disorders, leading to more options in the neurotech devices landscape. According to the World Health Organization (WHO), there is a significant disparity in access to treatment: high-income nations have up to 70 times more neurological experts per 100,000 people than low- and middle-income countries. Over 80% of neurological fatalities and health loss occur in low- and middle-income countries.


Neurotech Devices Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of neurotech devices is evaluated at USD 18.24 billion.

The global neurotech devices market size exceeded USD 16.16 billion in 2025 and is set to expand at a CAGR of over 14.3%, surpassing USD 61.5 billion revenue by 2035.

North America neurotech devices market will dominate around 41% share by 2035, fueled by high prevalence of neurological disorders and rising patient numbers.

Key players in the market include EndoStim Inc., Natus Medical, Allengers Medical Systems Ltd., Canon Medical Systems Corporation, Elekta Solutions AB, GE HealthCare Technologies Inc., Siemens Healthcare GmbH, The Magstim Company Limited, Tristan Technologies Inc., Abbott Laboratories Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos